Humanized Models for Greater Immuno-Oncology Preclinical Accuracy

Humanized mouse models can help researchers develop more efficacious immuno-oncology treatments. They offer researchers the opportunity to study interactions in vivo and to decipher mechanisms of action such as immune checkpoint inhibitors. Choosing the right disease model can greatly accelerate immuno-oncology research by improving pre-clinical accuracy and enhancing the chances of therapeutic success in clinical trials. This webinar explores how the latest humanized mouse models are advancing immuno-oncology by helping researchers study immune checkpoint blockades. Watch this webinar to learn more about: The advantages of using humanized mouse models in preclinical immuno-oncology research How the latest models are being used to develop novel RNA-based therapeutic strategies Drug testing approaches to improve your preclinical accuracy